MSK Ventures is a key program within the MSK Commercialization Ecosystem, with executive leadership from Anaeze Offodile II, MD, MPH, MSK’s Executive Vice President and Chief Strategy Officer. Whitney ...

Our research group has two primary focuses. One part of the lab focuses on determining the mechanisms of intracellular ion and metabolite transport, while the second studies protein nucleic acid ...

Soft tissue sarcoma, a diverse group of cancers that arise in the body’s connective tissue, is difficult to treat after it has spread. MSK clinicians are investigating the use of immunotherapy to ...